Maven Securities LTD Opti Nose, Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $262,800 - $536,400	-45,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$12.43 - $29.76 $62,150 - $148,800	-5,000 Reduced 10.0%	45,000 $566,000
Q2 2018 Aug 13, 2018	BUY	$18.75 - $28.46 $652,500 - $990,408	34,800 Added 228.95%	50,000 $1.4 Million
Q1 2018 May 15, 2018	SELL	$15.91 - $20.82 $161,709 - $211,614	-10,164 Reduced 40.07%	15,200 $304,000
Q4 2017 Feb 08, 2018	BUY	$15.2 - $20.76 $385,532 - $526,556	25,364	25,364 $480,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.